Sex, cardiovascular disease, and the inequities of COVID-19.
作者信息
Pyle W Glen
机构信息
IMPART Investigator Team, Dalhousie Medicine, Saint John, New Brunswick, Canada.
Department of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada.
出版信息
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H535-H537. doi: 10.1152/ajpheart.00416.2022. Epub 2022 Aug 19.
Abstract
摘要
相似文献
1
Sex, cardiovascular disease, and the inequities of COVID-19.性别、心血管疾病与新冠疫情的不平等现象
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H535-H537. doi: 10.1152/ajpheart.00416.2022. Epub 2022 Aug 19.
2
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.纽约市一家城市医疗中心的 COVID-19 患者种族与合并症及生存率的关系。
JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795.
3
An Overview on COVID-19 and its Effect on Cardiovascular Diseases.关于 COVID-19 及其对心血管疾病影响的概述。
Endocr Metab Immune Disord Drug Targets. 2021;21(11):1949-1953. doi: 10.2174/1871530321999201228214718.
4
COVID-19 and cardiovascular disease: what have we learned?2019冠状病毒病与心血管疾病：我们学到了什么？
Swiss Med Wkly. 2020 Dec 31;150:w20452. doi: 10.4414/smw.2020.20452. eCollection 2020 Dec 14.
5
Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry.因 COVID-19 住院患者的临床表现和结局的种族和民族差异：美国心脏协会 COVID-19 心血管疾病登记研究的结果。
Circulation. 2021 Jun 15;143(24):2332-2342. doi: 10.1161/CIRCULATIONAHA.120.052278. Epub 2020 Nov 17.
6
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".《Lean 欧洲 SARS-CoV-2 感染患者开放式调查（LEOSS）》的初步结果。
Infection. 2021 Feb;49(1):63-73. doi: 10.1007/s15010-020-01499-0. Epub 2020 Oct 1.
7
Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.SARS-CoV-2 大流行中的种族和民族差异：对美国多元化大都市人口 COVID-19 观察性登记的分析。
BMJ Open. 2020 Aug 11;10(8):e039849. doi: 10.1136/bmjopen-2020-039849.
8
Sex-Biased Vulnerability of the Heart to COVID-19.心脏对新冠病毒的性别差异易感性
Mayo Clin Proc. 2020 Nov;95(11):2332-2335. doi: 10.1016/j.mayocp.2020.09.017. Epub 2020 Sep 18.
9
COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?患有心血管疾病的COVID-19：它能帮助预测预后吗？
Heart Surg Forum. 2020 Nov 30;23(6):E895-E896. doi: 10.1532/hsf.3301.
10
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.COVID-19 时代糖尿病患者的心血管风险管理问题。
Diabetes Care. 2020 Jul;43(7):1427-1432. doi: 10.2337/dc20-0941. Epub 2020 May 14.
引用本文的文献
1
Sex as a biological variable for cardiovascular physiology.性别作为心血管生理学的生物学变量。
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H459-H469. doi: 10.1152/ajpheart.00727.2023. Epub 2023 Dec 15.
2
Guidelines on the use of sex and gender in cardiovascular research.心血管研究中性别和性别的使用指南。
Am J Physiol Heart Circ Physiol. 2024 Jan 1;326(1):H238-H255. doi: 10.1152/ajpheart.00535.2023. Epub 2023 Nov 24.
3
Feasibility of Precision Medicine in Hypertension Management-Scope and Technological Aspects.精准医学在高血压管理中的可行性——范围与技术层面
J Pers Med. 2022 Nov 7;12(11):1861. doi: 10.3390/jpm12111861.
本文引用的文献
1
The effects of biological sex and cardiovascular disease on COVID-19 mortality.生物性别和心血管疾病对 COVID-19 死亡率的影响。
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H397-H402. doi: 10.1152/ajpheart.00295.2022. Epub 2022 Jul 22.
2
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study.COVID-19 住院患者的心血管危险因素和临床结局：世界心脏联合会 COVID-19 研究的结果。
Glob Heart. 2022 Jun 15;17(1):40. doi: 10.5334/gh.1128. eCollection 2022.
3
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19.新冠病毒肺炎住院治疗6个月后的死亡率及心血管疾病转归的预测因素
J Clin Med. 2022 Jan 29;11(3):729. doi: 10.3390/jcm11030729.
4
Recalibrating healthcare to create a more equitable post-pandemic work environment.重新调整医疗保健，创造一个更加公平的大流行后工作环境。
Healthc Manage Forum. 2022 Jan;35(1):39-42. doi: 10.1177/08404704211054142. Epub 2021 Oct 26.
5
Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study.雌激素与 COVID-19 症状：COVID 症状研究中女性的关联。
PLoS One. 2021 Sep 10;16(9):e0257051. doi: 10.1371/journal.pone.0257051. eCollection 2021.
6
and variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.以及作为意大利COVID-19严重程度的性别和国家差异候选因素的变异和表达。
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098. doi: 10.18632/aging.103415.
7
Cardiac changes during the peri-menopausal period in a VCD-induced murine model of ovarian failure.围绝经期卵巢早衰模型小鼠心脏变化。
Acta Physiol (Oxf). 2019 Sep;227(1):e13290. doi: 10.1111/apha.13290. Epub 2019 May 31.
8
The X chromosome and sex-specific effects in infectious disease susceptibility.X 染色体与传染病易感性中的性别特异性效应。
Hum Genomics. 2019 Jan 8;13(1):2. doi: 10.1186/s40246-018-0185-z.
9
Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the Puzzle.雌激素、血管生成、免疫与细胞代谢：破解谜题。
Int J Mol Sci. 2018 Mar 15;19(3):859. doi: 10.3390/ijms19030859.
10
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.绝经和卵巢切除术会引发低度全身性炎症，低剂量雌激素或氯沙坦长期治疗或许可预防这种炎症。
J Immunol. 2009 Jul 15;183(2):1393-402. doi: 10.4049/jimmunol.0803157. Epub 2009 Jun 24.
Zotero 插件